| 发明名称 | Pharmaceutical composition comprising silkworm as an active ingredient for prevention and treatment of tissue injury by radiation | ||
| 摘要 | The present invention relates to a pharmaceutical composition for the prevention and treatment of tissue injury caused by irradiation which comprises silkworm hemolymph as an active ingredient. Particularly, when the silkworm hemolymph of the present invention was administered to an animal model with liver damage induced by irradiation, plasma AST and liver MDA were significantly decreased, indicating that the silkworm hemolymph of the invention can be effectively used as a composition for the prevention and treatment of disease caused by the exposure on radiation including tissue injury caused by irradiation, etc. | ||
| 申请公布号 | US9610306(B2) | 申请公布日期 | 2017.04.04 |
| 申请号 | US201615076352 | 申请日期 | 2016.03.21 |
| 申请人 | Korea Atomic Energy Research Institute | 发明人 | Park Sang Hyun;Jang Beom Su;Nam YouRee |
| 分类号 | A61K35/64 | 主分类号 | A61K35/64 |
| 代理机构 | Klarquist Sparkman, LLP | 代理人 | Klarquist Sparkman, LLP |
| 主权项 | 1. A method for the treatment of liver tissue injury that has been caused by irradiation comprising the step of administering a pharmaceutically effective dose of silkworm hemolymph to a subject with liver tissue injury that has been caused by irradiation. | ||
| 地址 | Daejeon KR | ||